Home > Pulmonology > ERS 2022 > Digitally enhanced therapy lowers treatment burden and costs in severe asthma

Digitally enhanced therapy lowers treatment burden and costs in severe asthma

Presented By
Prof. Richard Costello, Bon Secours Hospital Dublin, Ireland
Conference
ERS 2022
Trial
INCA-SUN
The treatment burden for patients with severe asthma was significantly reduced by using a digital tool set informing evidence-based care, including data on medication adherence, inhaler technique, and peak flow. Importantly, the lower treatment burden in the digital care group was not associated with a hampered asthma control. “Medical adherence, inhaler technique, and underlying comorbidities are practical challenges in the assessment of patients with asthma,” stated Prof. Richard Costello (Bon Secours Hospital Dublin, Ireland) [1]. Objective measures are needed to separate patients with difficult-to-treat asthma from those with severe asthma. The INCA-SUN trial (NCT02307669) randomised 216 patients with severe, uncontrolled asthma to the experimental arm, in which patients received personalised biofeedback on inhaler adherence, technique, and peak expira...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on